GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » Dividend-Payout-to-FFO

Japan Tissue Engineering Co (TSE:7774) Dividend-Payout-to-FFO


View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Japan Tissue Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.